Cargando…
The role of the oncostatin M/OSM receptor β axis in activating dermal microvascular endothelial cells in systemic sclerosis
BACKGROUND: Scleroderma (SSc) is a rare autoimmune disease characterized by vascular impairment and progressive fibrosis of the skin and other organs. Oncostatin M, a member of the IL-6 family, is elevated in SSc serum and was recognized as a significant player in various stages of fibrosis. The goa...
Autores principales: | Marden, G., Wan, Q., Wilks, J., Nevin, K., Feeney, M., Wisniacki, N., Trojanowski, M., Bujor, A., Stawski, L., Trojanowska, M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7393919/ https://www.ncbi.nlm.nih.gov/pubmed/32736577 http://dx.doi.org/10.1186/s13075-020-02266-0 |
Ejemplares similares
-
FLI1 and ERG protein degradation is regulated via Cathepsin B lysosomal pathway in human dermal microvascular endothelial cells
por: Mazzotta, Celestina, et al.
Publicado: (2020) -
Angiotensin II induces skin fibrosis: a novel mouse model of dermal fibrosis
por: Stawski, Lukasz, et al.
Publicado: (2012) -
In vivo affinity and target engagement in skin and blood in a first‐time‐in‐human study of an anti‐oncostatin M monoclonal antibody
por: Reid, Juliet, et al.
Publicado: (2018) -
Exploring the oncostatin M (OSM) feed-forward signaling of glioblastoma via STAT3 in pan-cancer analysis
por: Chen, Miao, et al.
Publicado: (2021) -
Molecular Simulation of Oncostatin M and Receptor (OSM–OSMR) Interaction as a Potential Therapeutic Target for Inflammatory Bowel Disease
por: Du, Qingqing, et al.
Publicado: (2020)